ADHD Diagnoses Rising Fast Across Youth
New data suggests shifts in diagnosis patterns after DSM-5 changes and the COVID era
ADHD diagnoses in young people have increased over the past decade, with notable acceleration after DSM-5 updates and the COVID-19 pandemic, especially among teenage girls and young women.
Study Details
A large population-based study examined ADHD diagnosis trends in over 2.7 million children and young adults in British Columbia, Canada, spanning 2003 to 2023. Researchers aimed to understand how diagnostic criteria changes and major societal disruptions may have influenced ADHD identification rates.
The study is particularly relevant because ADHD has historically been underdiagnosed in certain populations, especially females, and evolving diagnostic frameworks may be reshaping clinical recognition.
Methodology
Researchers conducted a retrospective cohort analysis using administrative health data, including physician visits, hospitalizations, and prescription records.
To ensure accuracy:
Individuals needed at least 3 years of continuous enrollment
Prior ADHD diagnoses were excluded to focus on new cases
Diagnoses were identified using validated clinical algorithms
The analysis compared incidence trends before and after two key events:
The DSM-5 update in 2013
The COVID-19 pandemic period beginning in 2020
Key Findings
ADHD diagnoses increased steadily after DSM-5 changes, with broader criteria allowing symptom onset up to age 12 instead of 7
A second, sharper rise occurred after the COVID-19 pandemic across all age groups
Teenage girls and young women showed some of the most significant increases, surpassing males of the same age for the first time
Pandemic-related stress and increased awareness may have contributed to higher diagnosis rates
Experts noted a dual concern of possible misdiagnosis alongside continued underdiagnosis in some populations
Implications for Practice
For patients and families:
Greater awareness may help individuals who were previously overlooked receive appropriate evaluation and support. However, not all attention or behavioral symptoms necessarily indicate ADHD, especially during periods of stress or disruption.
For healthcare providers:
Clinicians should balance increased recognition with careful differential diagnosis. ADHD symptoms can overlap with anxiety, depression, and situational stress, particularly in post-pandemic contexts.
For the healthcare system:
The findings highlight the need for better diagnostic precision, training in nuanced evaluation, and continued attention to underserved populations, especially females who may present differently.